Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology
(NASDAQ: PHVS) Delayed: 36.37 -1.63 (4.29%)
Previous Close $38.00    52 Week High $ 
Open $38.09    52 Week Low $ 
Day High $38.20    P/E N/A 
Day Low $36.08    EPS $ 
Volume 580,260